{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-303344","form_type":"8-K","ticker":"RACD","cik":"0002137777","company_name":"Research Alliance Corp IV","filed_at":"2026-07-14T20:58:44+00:00","discovered_at":"2026-07-14T21:00:01.412507+00:00","generated_at":"2026-07-14T21:00:06.651485+00:00","sec_items":["1.01","3.02","5.02","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Research Alliance Corp IV prices $75M IPO; shares to trade on Nasdaq under RACD","bullets":["IPO of 7,500,000 Class A shares at $10.00/share, gross proceeds $75M; closed July 14, 2026.","Private placement of 275,000 shares to sponsor at $10.00/share for $2.75M.","Net proceeds of $75M deposited in trust account with Continental Stock Transfer & Trust.","Alan Musso and John Maslowski appointed to board; committee assignments made.","Company to focus on healthcare/healthcare-related industries for initial business combination."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-303344","json":"https://secwatch.observer/filing/0001193125-26-303344.json","markdown":"https://secwatch.observer/filing/0001193125-26-303344.md","text":"https://secwatch.observer/filing/0001193125-26-303344.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2137777/000119312526303344/0001193125-26-303344-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2137777/000119312526303344/d138133d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-14T21:00:06.651485+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"012bd242ed","claim":"Alan Musso was appointed as Director at Research Alliance Corp IV.","evidence_excerpt":"On July 10, 2026, and in connection with the IPO, Alan Musso and John Maslowskiwere appointed to the board of directors of the Company (the “ Board ”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2137777/000119312526303344/0001193125-26-303344-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"5ca20f0768","claim":"John Maslowski was appointed as Director at Research Alliance Corp IV.","evidence_excerpt":"On July 10, 2026, and in connection with the IPO, Alan Musso and John Maslowskiwere appointed to the board of directors of the Company (the “ Board ”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2137777/000119312526303344/0001193125-26-303344-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}